7:00 AM-8:00 AM

Poster Session B: Patient Safety and Science of Quality

With complimentary continental breakfast

8:00 AM-9:30 AM

Welcome and General Session 4: Patient-Centered Care—Hearing the Patient's Voice to Assess and Promote High-Quality Cancer Care
David Rice, PhD, RN, NP—Co-Chair

City of Hope

Larissa Temple, MD—Co-Chair
University of Rochester


Monika K. Krzyzanowska, MD, MPH, FRCPC
Princess Margaret Cancer Centre
Welcome of the Day


Neeraj K. Arora, PhD
Can You Hear Me Now? Importance of Assessing Patients' Cancer Care Experiences


Ethan M. Basch, MD, MSc, FASCO
The University of North Carolina at Chapel Hill
Bringing the Patient Voice into Care Delivery and Quality Assessment


Gwendolyn P. Quinn, PhD
H. Lee Moffitt Cancer & Research Institute
Suppressed Voices: Are We Listening to the Perspectives of Underserved Patients With Cancer and Survivors


Kate Niehaus, MBA
Patient and Family Advisory Council for Quality, Memorial Sloan Kettering Cancer Center
Using Patient and Family Advisory Councils as a Mechanism for the Patient's Voice


Panel Question and Answer

9:30 AM-10:00 AM


10:00 AM-11:30 AM

General Session 5: Using Electronic Medical Records to Collect Data, Report on Aggregate Experiences, and Adapt to Changing Knowledge
Natalie R. Dickson, MD—Co-Chair

Tennessee Oncology

Jennifer Malin, MD, PhD—Co-Chair
United Healthcare


Michael J. Hassett, MD, MPH
Dana-Farber Cancer Institute
How Many Clicks Are Too Many: Usability Considerations in Oncology EHRs


Amy Abernethy, MD, PhD
Flatiron Health
Quality Reporting: Challenges in Aggregating Data from the EHR


Mark A. Sitarik, MD
US Oncology
Better and Smarter: Capturing New Genomic Information into the EHR


Panel Question and Answer

11:30 AM-1:00 PM

Poster Session B: Patient Safety and Science of Quality (Continued)

With complimentary boxed lunch

11:45 AM-12:30 PM

Poster Walks

Learn more about Poster Walks


Steven Clauser, PhD, MPA 

Patient-Centered Outcomes Research Institute 


Ari-Nareg Meguerditchian, MD, FRCS

McGill University Health Centre

1:00 PM-2:30 PM

Oral Abstract Session B

Carolyn B. Hendricks, MD—Co-Chair

Maryland Oncology Hematology

Craig Earle, MD, MSc—Co-Chair

Ontario Institute for Cancer Research


Abstract 36: Near miss or safety incident in patients treated with radiotherapy: What are the contributing factors?

First author: Greg Judy

Abstract 37: Significant and sustained reduction in chemotherapy errors though improvement science.

First author: Brian Weiss

Abstract 51: Reviewing systemic treatment regimens to reduce unintentional errors.

First author: Andrea Crespo


Discussion: Joseph O. Jacobson, MD, MSc, FASCO

Dana-Farber Cancer Institute



Abstract 52: Reducing overuse of colony-stimulating factors without compromising patient safety: Evidence from a decision-support enabled utilization management in patients with lung cancer receiving chemotherapy.

First author: Gboyega Adeboyeje

Abstract 3: Cost and survival analysis before and after implementation of Dana-Farber Clinical Pathways for Patients with Stage IV Non-Small Cell Lung Cancer.

First author: Yichen Zhang


Discussion: Thomas J. Smith, MD, FACP, FASCO, FAAHPM

Johns Hopkins Medicine


Panel Question and Answer

2:30 PM-3:00 PM


3:00 PM-4:30 PM

General Session 6: Successful Models for Integrating Quality and Patient Safety Into Health Care Organizations

Joseph O. Jacobson, MD, MSc, FASCO—Chair
Dana-Farber Cancer Institute


Brent James, MD, MStat
Intermountain Healthcare
Advancing Quality: Intermountain Health, Salt Lake City


Panel Question and Answer